Opticrom Aqueous (Sodium Cromoglicate)

Sodium cromoglicate, the active ingredient in Opticrom Aqueous, is a mast cell stabilizer presented as an aqueous ophthalmic solution for ocular use. It helps control allergic inflammation of the eye, particularly in patients with allergic conjunctivitis and vernal keratoconjunctivitis.

GNH USA supplies Opticrom Aqueous as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required, and comprehensive regulatory support for importers.

Opticrom Aqueous, a mast cell stabilizer, is used to manage ocular allergic conditions by preventing mediator release.

- Allergic conjunctivitis: reduces ocular itching, redness and tearing associated with seasonal allergens. - Vernal keratoconjunctivitis: helps control chronic inflammation and photophobia in patients with this severe allergic eye disease. - Seasonal allergic conjunctivitis: alleviates symptoms during pollen seasons by stabilizing mast cells in the conjunctiva.

Adverse reactions are generally mild and localized to the eye.

Common Side Effects: - Burning or stinging sensation on instillation. - Transient blurred vision. - Mild eye irritation or foreign‑body sensation. - Temporary conjunctival hyperemia. - Tearing or increased lacrimation. - Mild eyelid edema.

Serious or Rare Side Effects: - Allergic contact dermatitis of the eyelid or peri‑ocular skin. - Severe eye pain or persistent redness. - Vision loss or sudden visual acuity changes. - Corneal ulceration or keratitis. - Anaphylactic reaction (extremely rare).

Before prescribing Opticrom Aqueous, clinicians should consider the following safety measures.

- Assess patient history: verify no known hypersensitivity to sodium cromoglicate or excipients. - Evaluate ocular surface: avoid use in active eye infections or severe corneal disease. - Contact lens wearers: remove lenses before instillation and wait several minutes before reinserting. - Concomitant ocular medications: monitor for additive irritation when used with other drops. - Pediatric use: safety and efficacy have not been established in children under the recommended age. - Store at below 25°C: keep in the original container, protect from light and moisture.

Opticrom Aqueous may interact with other ophthalmic agents, requiring careful management.

Major Interactions (Avoid): - Concurrent use with other mast cell stabilizers: may increase local irritation. - Simultaneous administration with preservative‑containing drops: risk of cumulative ocular surface toxicity.

Moderate Interactions (Monitor Closely): - Systemic antihistamines: may reduce tear production, potentially worsening dryness. - Topical corticosteroids: monitor for additive immunosuppression. - Contact lens solutions: ensure compatibility to avoid lens discoloration or discomfort.